ANTENGENE-B (06996) received a $60 million upfront payment from UCB for ATG-201.
Deckee Pharmaceuticals-B (06996) announced that the company (as licensor) has entered into a global exclusive licensing agreement with UCB (as licensee) for the CD19/CD3 bispecific T cell engager (TCE) antibody ATG-201. The group has already received an initial payment of $60 million from UCB. Receiving this milestone payment under the agreement with UCB further strengthens the group's cash position, providing strong financial support for advancing the group's innovative drug pipeline and accelerating access to more patients.
ANTENGENE-B (06996) announces that it has entered into a global exclusive licensing agreement with UCB regarding the CD19/CD3 bispecific T-cell engager (TCE) antibody ATG-201, with ANTENGENE-B as the licensor and UCB as the licensee. The Group has received an initial payment of $60 million from UCB. The receipt of this milestone payment under the agreement with UCB further strengthens the Group's cash position, providing strong financial support for the development of the Group's innovative drug pipeline and accelerating access to more patients.
Related Articles
TASTEGOURMET GP (08371) plans to open a new Kin Long Teppanyaki restaurant in Hong Kong.
SSY GROUP (02005): Mabalocevir has been approved by the National Medical Products Administration for registration as an active pharmaceutical ingredient for use in marketed formulations.
CGN NEW ENERGY (01811) completed a total electricity generation of 1,331.5 GWh in June, representing a decrease of 5.1% compared to the same period last year.
TASTEGOURMET GP (08371) plans to open a new Kin Long Teppanyaki restaurant in Hong Kong.
SSY GROUP (02005): Mabalocevir has been approved by the National Medical Products Administration for registration as an active pharmaceutical ingredient for use in marketed formulations.
CGN NEW ENERGY (01811) completed a total electricity generation of 1,331.5 GWh in June, representing a decrease of 5.1% compared to the same period last year.
RECOMMEND
